Microsatellite alterations in African Americans with head and neck cancer

Laryngoscope

Volumn 114, Issue 9 I, 2004, Pages 1619-1624

  Yoo, George H ^a   Nguyen, Nghia X ^a   Du, Wei ^a   Schwartz, Ann G ^a   Land, Susan ^a   Lin, Ho Sheng ^a   Kewson, Danny ^a   Murphy, Leslie L ^b   Cilluffo, Dave ^b   Ensley, John F ^a   Tainsky, Michael A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Quality Program Management   (United States)

Author keywords

Head and neck cancer; Loss of heterozygosity; Microsatellite analysis

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FLUORESCENCE; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CROSS-SECTIONAL STUDIES; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LOSS OF HETEROZYGOSITY; MALE; MICHIGAN; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE;

EID: 4644220148     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200409000-00021     Document Type: Article

References (32)

1. Caplan DJ, Hertz-Picciotto I. Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent 1998;58:36-43.
2. Goldberg HI, Lockwood SA, Wyatt SW, Crossett LS. Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer 1994;74:565-572.
3. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-962.
4. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 1993;85:465-473.
5. van Rensburg EJ, Engelbrecht S, van Heerden WF, et al. Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample. Hum Mutat 1998;11:39-44.
6. Blaszyk H, Vaughn CB, Hartmann A, et al. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet 1994;343:1195-1197.
7. Shiao YH, Chen VW, Scheer WD, et al. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 1995;55:1485-1490.
8. Lazar AD, Winter MR, Nogueira CP, et al. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res 1998;4:2787-2793.
9. Pearlstein RP, Benninger MS, Carey TE, et al. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 1998;21:333-339.
10. Chomchai JS, Du W, Sarkar FH, et al. Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 1999;109:455-459.
11. Lee DJ, Koch WM, Yoo G, et al. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res 1997;3:501-505.
12. Li X, Lee NK, Ye YW, et al. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 1994;86:1524-1529.
13. Schantz SP, Huang Q, Shah K, et al. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers. Carcinogenesis 2000;21:1239-1246.
14. Spitz MR, Hsu TC, Wu X, Fueger, et al. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
15. Weissenbach J, Gyapay G, Dib C, et al. A second-generation linkage map of the human genome [see comments]. Nature 1992;359:794-801.
16. Liloglou T, Maloney P, Xinarianos G, et al. Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors. Int J Oncol 2000;16:5-14.
17. Chetty R, Naidoo R, Schneider J. Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology. Mol Pathol 1998;51:35-38.
18. Magnusson PK, Wilander E, Gyllensten U. Analysis of loss of heterozygosity in microdissected tumor cells from cervical carcinoma using fluorescent dUTP labeling of PCR products. Biotechniques 1996;21:844-847.
19. Sobrido MJ, Barros F, Lema M, et al. Assessing microsatellite instability with semiautomated fluorescent technology: application to the analysis of primary brain tumors. Electrophoresis 2000;21:1471-1477.
20. Tokunaga E, Oki E, Oda S, et al. Frequency of microsatellite instability in breast cancer determined by high-resolution fluorescent microsatellite analysis. Oncology 2000;59:44-49.
21. Nawroz H, van der Riet P, Hruban RH, et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-1155.
22. Yoo GH, Xu HJ, Brennan JA, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994;54:4603-4606.
23. Oda S, Oki E, Maehara Y, Sugimachi K. Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res 1997;25:3415-3420.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
25. Lee, K, Strauss, M. Head and neck cancer in blacks. J Natl Med Assoc 1994;86:530-534.
26. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
27. Ford JG, Li Y, O'Sullivan MM, et al. Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis 2000;21:1971-1975.
28. Taioli E, Ford J, Trachman J, Li Y, et al. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 1998;19:813-817.
29. Blons H, Cabelguenne A, Carnot F, et al. Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma. Int J Cancer 1999;84:410-415.
30. Cabelguenne A, Blons H, de Wi I, et al. p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol 2000;18:1465-1473.
31. Bockmuhl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 1996;56:5325-5329.
32. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-2492.